Answer:
The potential risks associated with plant-based pharmaceuticals include: pollen transfer to related species, contamination of non-transgenic crops intended for the consumption by humans, allergic reactions to the drugs produced from the genetically engineered plant, and persistence of genetically engineered material to persist in the environment and accumulate in non-target organisms. Risk assessment of plant-made pharmaceuticals should be reviewed on a case-by-case basis because the plants used to produce proteins each have different risks associated with them.
Answer:
The sympathetic chain contains a group of cell bodies called the sympathetic chain GANGLIA. This structure contains a second cell body for the sympathetic nervous system, the first in the series being found in the THORACOLUMBAR REGIONS' lateral horn of spinal segments T1-L2. The purpose of the VENTRAL AND DORSAL rami is to carry visceral motor and visceral sensory neurons to and from this sympathetic chain.
Explanation:
The sympathetic trunks (sympathetic chain, gangliated cord) are a paired bundle of nerve fibers that run from the base of the skull to the coccyx.
See the picture attached.
A peptide bond is formed by a condensation (water-loss) reaction between the carboxyl group of oneamino acid<span> and the </span>amino<span> group of the next </span>amino acid<span> occurring in a protein. Thus, proteins are formed by the linear </span>arrangement<span> of </span>amino acids<span> in a particular order</span>
